Skip to main content
Figure 1 | Malaria Journal

Figure 1

From: Pharmacokinetics and pharmacodynamics of fosmidomycin monotherapy and combination therapy with clindamycin in the treatment of multidrug resistant falciparum malaria

Figure 1

Observed and predicted median plasma concentrations of fosmidomycin (by one-compartment open model with first-order absorption and elimination with absorption lag time) given as (a) monotherapy (1,200 mg every 8 hours for 7 days), and (b) combination therapy with clindamycin (900 mg every 12 hours for 7 days).

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us